Figure 1. Roya Lisboa, RN, holding a SorbaView bandage (Centurion Medical Products).
Small innovations can make a big difference. It’s a recurrent theme in interventional cardiology. Small changes or new application of a common piece or equipment, supply, or method can make a difference in your lab.1,2
Figure 2. The Tegederm bandage being applied to the radial sheath. Lower right, view of draping for our radial procedures using the Armen glove method.3
Last week, Roya Lisboa (Figure 1), one of our super cath lab nurses, handed me an IV bandage to secure the radial sheath. I’d been complaining, as many of my colleagues have reported, that the usual Tegederm clear plastic bandage (Figure 2) with a slit, holds the sheath in place for most routine cases but fails for longer procedures, especially when blood gets under the plastic.
Figure 3. The SorbaView bandage. Left, adhesive side before removal of paper covers; middle, front side of SorbaView bandage; right, different size SorbaView bandage showing clear window and a port to see hub of catheter/sheath/IV. Blue lines are reinforcing tapes incorporated into bandage.
The SorbaView bandage (Centurion Medical Products) (Figure 3) has a clear window and fabric adhesive border with a locking piece of adhesive added after the bandage is placed. It is usually used to protect IV needles and catheters. The fabric border prevents blood from leaking into the puncture area. To secure the radial sheath, we made sure to attach the fabric adhesive to the hub of the sheath with the side arm passing under the adhesive and the locking patch over the side arm (Figure 4).
Figure 4A. Application of the SorbaView bandage to the radial sheath. The fabric tape is adhered to the sheath hub. The side arm is looped to the top of the arm and covered by the SorbaView clear window and fabric border.
I asked my expert colleagues what they used for securing their radial sheaths and the answers were interesting:
Most respondents used Tegederm, but complained that its securing function is short-lived and if blood gets under it, it is a mess and stops working. This usually occurs involving a long case with multiple catheter exchanges.
Figure 4B. Final SorbaView application with locking patch holding the side arm as it exits the sheath. The bandage stayed dry for the entire procedure and was easy to remove.
Several operators use long sheaths with no securing technique needed.
Several operators use a suture if the sheath needs to be secured for long case.
One European operator doesn’t use sheaths and goes sheathless for his procedures.
Figure 5. Three sheath-securing devices. Left, Statlock (Maquet); top right, StayFIX (Merit Medical); bottom right, StatLock arterial ultra-stabilization device (Bard Access Systems).
Several other devices available in our lab were investigated but none seemed suitable (Figure 5). While only a small change in our radial technique, the use of a new securing method may be a big advance for the procedure. It’s always a good idea to keep your eyes open in the cath lab.
References
Kern MJ. New ideas from cardiac cath lab staff. Cath Lab Digest. 2008 Mar; 16(4). Available online at https://www.cathlabdigest.com/articles/New-Ideas-Cardiac-Cath-Lab-Staff. Accessed Dec 12, 2017.
Kern MJ. Small innovations can make a big difference: the role of staff initiatives to drive efficiency in the cath lab. Cath Lab Digest. 2017 Feb; 25(2). Available online at https://www.cathlabdigest.com/article/Small-Innovations-Can-Make-Big-Difference-Role-Staff-Initiatives-Drive-Efficiency-Cath-Lab. Accessed December 12, 2017.
Kern MJ. The Armen glove for radial access prep — a better way. Cath Lab Digest. 2010 May; 18(5). Available online at https://www.cathlabdigest.com/articles/The-Armen-Glove-Radial-Access-Prep-%E2%80%93-A-Better-Way. Accessed December 12, 2017.
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
Scientia's novel access platform is designed to improve navigability through complex anatomy and simplify neurovascular procedures. By enabling faster and more reliable access, these technologies improve procedural efficiency.
Scientia's novel access platform is designed to improve navigability through complex anatomy and simplify neurovascular procedures. By enabling faster and more reliable access, these technologies improve procedural efficiency.
"By using the EggNest system, we can provide the entire team with protection that is superior to the status quo, by either going apron-free, or while wearing aprons that feel like a light vest," said Santiago Garcia, MD, the study’s lead...
"By using the EggNest system, we can provide the entire team with protection that is superior to the status quo, by either going apron-free, or while wearing aprons that feel like a light vest," said Santiago Garcia, MD, the study’s lead...
"This first look at contemporary data of the growing adoption of angiography-derived physiology (ADP) in the U.S. shows similar clinical outcomes including death, MI and revascularization through 2 years when compared with invasive pressure...
"This first look at contemporary data of the growing adoption of angiography-derived physiology (ADP) in the U.S. shows similar clinical outcomes including death, MI and revascularization through 2 years when compared with invasive pressure...
Dr. Amish Raval reported that patients receiving the autologous CardiAMP cell therapy under investigation demonstrated positive evidence of decreased pathological left ventricular remodeling over time compared to patients not receiving the...
Dr. Amish Raval reported that patients receiving the autologous CardiAMP cell therapy under investigation demonstrated positive evidence of decreased pathological left ventricular remodeling over time compared to patients not receiving the...
"The RELIEF-FIH study provides encouraging early evidence on a novel approach to HF congestion management," stated Dr. Alex Rothman. "By targeting the negative physiological cardiorenal loop, the Relief System modulates venous congestion in...
"The RELIEF-FIH study provides encouraging early evidence on a novel approach to HF congestion management," stated Dr. Alex Rothman. "By targeting the negative physiological cardiorenal loop, the Relief System modulates venous congestion in...
A wound that remains open for longer than a month is classified as chronic. Worldwide, about 12 million people experience chronic wounds each year, including roughly 4.5 million in the United States. Approximately one in five of these...
A wound that remains open for longer than a month is classified as chronic. Worldwide, about 12 million people experience chronic wounds each year, including roughly 4.5 million in the United States. Approximately one in five of these...
Limiting sugar consumption during early childhood may reduce the risk of serious heart problems later in life. A study published in The BMJ, based on data from the end of sugar rationing in the United Kingdom in 1953, found that people...
Limiting sugar consumption during early childhood may reduce the risk of serious heart problems later in life. A study published in The BMJ, based on data from the end of sugar rationing in the United Kingdom in 1953, found that people...
SALT LAKE CITY, UT — VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
Blood clot removal...
SALT LAKE CITY, UT — VentiV Scientific announced the FDA clearance of VentiV Mechanical Thrombectomy system to remove blood clots from the peripheral vasculature including the new VentiV Pulse platform.
Blood clot removal...
Munich, Germany – Preliminary results from an Italian registry describe the risk profile of women experiencing acute coronary syndromes and provide insights to improve management.1 These findings were presented today at the EAPCI Summit 2026,...
Munich, Germany – Preliminary results from an Italian registry describe the risk profile of women experiencing acute coronary syndromes and provide insights to improve management.1 These findings were presented today at the EAPCI Summit 2026,...
